IVPost
FDA approves first treatment for certain patients with Erdheim-Chester Disease, a rare blood cancer
- Details
- Written by Angela Stark
- Category: Medical News
The U.S. Food and Drug Administration expanded the approval of Zelboraf (vemurafenib) to include the treatment of certain adult patients with Erdheim-Chester Disease (ECD), a rare cancer of the blood. Zelboraf is indicated to treat patients whose cancer cells have a specific genetic mutation known as BRAF V600. This is the first FDA-approved treatment for ECD.
Implementation of FDA’s streamlined development and review pathway for consumer tests that evaluate genetic health risks
- Details
- Written by FDA Commissioner Scott Gottlieb, M.D.
- Category: Latest News
At a time when people are more aware of and engaged in their health care than ever before, genetic risk testing can provide helpful information about an individual's predisposition for certain diseases and conditions. These tests can prompt consumers to be more engaged in pursuing the benefits of healthy lifestyle choices and more aware of their health risks. Consumers are increasingly embracing genetic health risk (GHR) testing to better understand their individual risk for developing diseases. This engagement prompts some people to make more informed lifestyle choices.
Million Hearts® Recognizes the 2017 Hypertension Control Champions
- Details
- Written by IVP
- Category: Health News
The Centers for Disease Control and Prevention announced 24 winners of the 2017 Million Hearts Hypertension Control Challenge.
Fentanyl involved in over half of opioid overdose deaths in 10 states
- Details
- Written by CDC
- Category: Latest News
Over half of people in 10 states who died of opioid overdoses during the second half of 2016 tested positive for fentanyl, according to new data published today in CDC's Morbidity and Mortality Weekly Report (MMWR) Early Release.
Getting Ahead of the Next Pandemic: Is the World Ready?
- Details
- Written by IVPost
- Category: Health News
When a deadly mystery illness was detected in Liberia in April 2017, first responders were on the ground within 24 hours. Through the Ministry of Health's quick action and collaboration with global partners, the cause of the outbreak was identified as meningococcal disease and contained with only 31 cases and 13 deaths. In stark contrast, when Ebola struck Liberia just three years ago, it took the country months to mount an effective response; thousands of lives were lost as responders raced to control the growing epidemic.
Mayo Clinic Board of Trustees re-elects Di Piazza as board chair
- Details
- Written by Karl W Oestreich
- Category: Latest News
The Mayo Clinic Board of Trustees re-elected Samuel Di Piazza as its chair at its quarterly meeting today. He will serve another four-year term.
Page 41 of 49